22 May 2013
Keywords: genta, updates, ph, iii, genasense, trial, firm
Article | 23 May 2005
US firm Genta has updated results from its Phase III trial of Genasense (oblimersen sodium) Injection in patients with relapsed ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 May 2005
16 May 2005
21 May 2013
© 2013 thepharmaletter.com